Why Functional Neurological Disorder is Not Simulation

The question of whether functional neurological disorder (FND) is genuine — or whether patients are simulating, exaggerating, or seeking attention — has burdened this field for decades. The review by Edwards, Yogarajah, and Stone addresses this question systematically and comprehensively, drawing on clinical observations, neuroimaging, electrophysiology, and psychophysics.

1Clinical consistency

FND symptoms show consistent internal patterns that differ from the patterns one would expect in deliberate simulation. Motor symptoms of FND follow neurobiological logic — they are influenced by attention, distraction, and suggestion in predictable ways that a simulator could not sustain over time. The Hoover sign, tremor entrainment, and other positive clinical signs exploit precisely these attentional mechanisms, which are not under conscious control.

2Behaviour during investigations

Studies that systematically observed patients with FND during blind investigation (e.g. EEG video monitoring during seizures) show that their behaviour is not consistent with deliberate performance. The duration of episodes, the motor patterns, and the post-ictal state in functional seizures differ characteristically from epileptic seizures — but also from what actors or simulators produce when asked to reproduce such an episode.

3Prognosis

If FND were simulation, we would expect it to disappear as soon as the external motive for simulation disappeared. This is not what we observe. FND persists — often for years — even after the elimination of potential secondary gains. Long-term follow-up studies show that many patients remain symptomatic even years after diagnosis, regardless of whether disability claims have been resolved.

4Experimental evidence — fMRI, EEG, and psychophysics

fMRI studies show altered activation of the prefrontal cortex, amygdala, and supplementary motor area in patients with FND — consistent with a model of disrupted motor preparation and abnormal inhibition. EEG studies show abnormal pre-movement potentials. Psychophysical studies demonstrate altered proprioceptive processing and changed body ownership. These are measurable biological changes, not personality traits.

5Active inference and predictive processing

The authors introduce the active inference framework as a compelling explanatory model for FND. In this model, the brain continuously generates predictions about sensory input and motor outcomes. In FND, these predictions become "stuck" — the brain generates a strong prediction of weakness, tremor, or altered sensation, and this prediction overrides incoming sensory evidence. The result is a real subjective experience of the symptom, without a structural lesion to explain it. This model makes testable predictions and has begun to guide new therapeutic approaches.

6Perception of simulation

The authors devote a section to the cognitive biases that lead clinicians to incorrectly identify FND as simulation. Key among these: the assumption that symptoms that respond to psychological intervention must have had a psychological (intentional) cause; and the tendency to attribute unexplained symptoms to patient motivation rather than neurobiological mechanism. These biases are not harmless — they lead to withheld treatment, damaged trust, and worsened outcomes.

7Overlap with other conditions

FND does not exist in isolation. It frequently co-occurs with anxiety disorders, depression, PTSD, and other neurological conditions (including epilepsy). This co-occurrence does not indicate that FND is a "symptom" of these conditions — rather, it reflects shared neurobiological vulnerabilities and overlapping pathophysiological mechanisms. Treatment of comorbidities is part of comprehensive management of FND, but does not substitute it.

8Clinical implications

The review concludes with practical recommendations for clinical practice. Key among them: the diagnosis of FND should be made positively, on the basis of clinical signs, and communicated clearly to the patient. The explanation should be honest and accessible — neither dismissive ("it's all in your head") nor overly technical. A multidisciplinary team — neurologist, psychologist, physiotherapist — produces better outcomes than any single-specialist approach.

9Transfer to the paediatric population

The review primarily concerns adults, but the conclusions transfer to the paediatric population with important modifications. Children are less likely to maintain deliberate simulation over long periods; their symptoms are more closely tied to current psychosocial stressors; and their nervous systems are more plastic — which, on the one hand, makes them more susceptible to FND, and on the other, makes them more responsive to treatment. Early diagnosis and a team approach are particularly important in children.


Psychosomatic Disorders and their Classifications

The classification of psychosomatic disorders has undergone considerable changes in the last decade. The transition from ICD-10 to ICD-11 and the DSM-5 revision have brought a conceptual shift that is relevant to clinical practice as well as to research and education. This article provides an overview of the key categories and their evolution.

1Somatoform disorders in ICD-10 and their critique

ICD-10 category F45 — somatoform disorders — groups conditions characterised by "medically unexplained symptoms." The main subcategories include: somatisation disorder (F45.0), undifferentiated somatoform disorder (F45.1), hypochondriacal disorder (F45.2), somatoform autonomic dysfunction (F45.3), and persistent somatoform pain disorder (F45.4).

The central criterion of "medically unexplained symptoms" has attracted criticism on several grounds. First, it relies on a false binary between "explained" and "unexplained" symptoms, while in reality most conditions lie on a continuum. Second, it is implicitly stigmatising — the patient is told there is "nothing to explain." Third, the criterion becomes less relevant as our understanding of the neurobiology of pain and stress improves: these symptoms increasingly do have biological explanations, even if structural damage cannot be demonstrated.

2Bodily Distress Disorder (BDD) in ICD-11

ICD-11 (published 2019, applicable from 2022) abandons the "medically unexplained symptoms" criterion and introduces Bodily Distress Disorder (BDD) as a unified replacement for most ICD-10 F45 categories.

Diagnostic criteria for BDD (ICD-11):

(1) The presence of bodily symptoms that are distressing to the individual; and
(2) Excessive attention devoted to the symptoms, which persists despite appropriate clinical investigation and reassurance; and
(3) Bodily symptoms and associated preoccupation cause significant distress or functional impairment; and
(4) Symptoms are typically present on most days, for a period of at least several months.

BDD is classified on a severity scale (mild, moderate, severe) depending on the degree of impairment and the extent to which attention to symptoms interferes with everyday life. The focus shifts from aetiology to the patient's experience and functional consequences.

3Somatic Symptom Disorder (SSD) in DSM-5

DSM-5 (2013) introduced Somatic Symptom Disorder (SSD) as a replacement for somatisation disorder and undifferentiated somatoform disorder. Like ICD-11 BDD, SSD abandons the criterion of medically unexplained symptoms.

Diagnostic criteria for SSD (DSM-5):

(A) One or more somatic symptoms that are distressing or result in significant disruption of daily life;

(B) Excessive thoughts, feelings, or behaviours related to the somatic symptoms or associated health concerns as manifested by at least one of: (1) disproportionate and persistent thoughts about the seriousness of one's symptoms; (2) persistently high level of anxiety about health or symptoms; (3) excessive time and energy devoted to these symptoms or health concerns;

(C) Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6 months).

A key innovation of DSM-5 is the focus on the cognitive and emotional response to symptoms — not only on the symptoms themselves. This allows diagnosis even when symptoms have a partially explained organic basis, as long as the response to them is disproportionate.

SSD in DSM-5 is approximately equivalent to BDD in ICD-11, although there are differences in operationalisation and threshold. Research comparability between the two systems remains a challenge.

4Functional Neurological Disorder (FND)

FND occupies a special place in the classification landscape. In DSM-5 it appears as "Conversion Disorder (Functional Neurological Symptom Disorder)" within the somatic symptom and related disorders chapter. In ICD-11 it is classified under "Dissociative neurological symptom disorder" within dissociative disorders — a placement that reflects historical tradition rather than current clinical conceptualisation.

Critically, both classification systems have retained FND as a separate category from SSD/BDD. The main reason: FND has distinct neurological features, a positive clinical diagnosis (not by exclusion), and specific treatment modalities (neurological physiotherapy, specialised psychological therapy). Treating it within the broader SSD category would undermine both the specificity of treatment and the clarity of communication with patients.

The ongoing discussion around the classification of FND reflects deeper tensions in the field: between neurology and psychiatry, between explanation-based and experience-based diagnosis, and between different cultural traditions of understanding the mind–body relationship. Current consensus favours a neurobiological model of FND as a disorder of neural network function — a model that is both scientifically grounded and clinically productive.

References
  1. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: WHO; 2019.
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: APA; 2013.
  3. Edwards MJ, Yogarajah M, Stone J. Why functional neurological disorder is not feigning or malingering. Nat Rev Neurol. 2023;19:246–256.
  4. Stone J, Hewett R, Carson A, Warlow C, Sharpe M. The 'disappearance' of hysteria: historical mystery or illusion? J R Soc Med. 2008;101(1):12–18.
  5. Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223–228.
  6. Henningsen P, Zipfel S, Sattel H, Creed F. Management of Functional Somatic Syndromes and Bodily Distress. Psychother Psychosom. 2018;87(1):12–31.
  7. Fröhlich C, Jacobi F, Wittchen HU. DSM-IV pain disorder in the general population. An exploration of the structure and threshold of medically unexplained pain symptoms. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):187–196.
  8. Kirmayer LJ, Groleau D, Looper KJ, Dao MD. Explaining medically unexplained symptoms. Can J Psychiatry. 2004;49(10):663–672.
  9. Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113–1119.
  10. Reuber M, Elger CE. Psychogenic nonepileptic seizures: review and update. Epilepsy Behav. 2003;4(3):205–216.
  11. van der Feltz-Cornelis CM, Allen SF, Ader HJ. Routine screening of somatic symptom disorder, anxiety disorder, depression and alcohol use in general practice. J Psychosom Res. 2018;111:106–115.
  12. Perez DL, Matin N, Barsky A, et al. Cingulo-insular structural alterations associated with psychogenic nonepileptic seizures, major depression and conversion disorder. Brain Struct Funct. 2017;222(2):707–720.
  13. Garber J, Walker LS, Zeman J. Somatization symptoms in a community sample of children and adolescents: further validation of the Children's Somatization Inventory. Psychol Assess. 1991;3(4):588–595.